Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Brown

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
ACS Medicinal Chemistry Letters|November 17, 2022
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding ModeStacey M Southall, Joydeep Banerjee, Jason Brown, et al.
Nature Communications|December 27, 2024
Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptorThomas L Williams, Grégory Verdon, Rhoda E Kuc, et al.
Urologic Oncology|June 19, 2026
Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in OhioDevika Nandwana, Jayant Siva, Laura Davis, et al.
British Journal of Pharmacology|April 11, 2006
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonistRichard J Wilson, Gerard M P Giblin, Susan Roomans, et al.
Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Drug Discovery of <i>N</i>-((<i>R</i>)-3-(7-Methyl-1<i>H</i>-indazol-5-yl)-1-oxo-1-(((<i>S</i>)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3-<i>d</i>][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of MigraineSarah J Bucknell, Mark A Ator, Alastair J H Brown, et al.
Journal of Medicinal Chemistry|April 16, 2021
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical CandidateHuikai Sun, Holger Monenschein, Hans H Schiffer, et al.
JMIR Research Protocols|May 26, 2020
Effectiveness of Group Cognitive Behavioral Therapy and Exercise in the Management of Major Depressive Disorder: Protocol for a Pilot Randomized Controlled TrialMojtaba Yekrang Safakar, Marianne Hrabok, Liana Urichuk, et al.
Plos One|February 9, 2010
Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variantsDavid Metzgar, Christopher A Myers, Kevin L Russell, et al.
ACS Chemical Neuroscience|March 4, 2022
Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand ComplexesAndrew D Cansfield, Mark A Ator, Joydeep Banerjee, et al.
Molecular Autism|October 26, 2019
Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autismHyung-Goo Kim, Jill A Rosenfeld, Daryl A Scott, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
ACS Medicinal Chemistry Letters|November 17, 2022
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding ModeStacey M Southall, Joydeep Banerjee, Jason Brown, et al.
Nature Communications|December 27, 2024
Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptorThomas L Williams, Grégory Verdon, Rhoda E Kuc, et al.
Urologic Oncology|June 19, 2026
Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in OhioDevika Nandwana, Jayant Siva, Laura Davis, et al.
British Journal of Pharmacology|April 11, 2006
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonistRichard J Wilson, Gerard M P Giblin, Susan Roomans, et al.
Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Drug Discovery of <i>N</i>-((<i>R</i>)-3-(7-Methyl-1<i>H</i>-indazol-5-yl)-1-oxo-1-(((<i>S</i>)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3-<i>d</i>][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of MigraineSarah J Bucknell, Mark A Ator, Alastair J H Brown, et al.
Journal of Medicinal Chemistry|April 16, 2021
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical CandidateHuikai Sun, Holger Monenschein, Hans H Schiffer, et al.
JMIR Research Protocols|May 26, 2020
Effectiveness of Group Cognitive Behavioral Therapy and Exercise in the Management of Major Depressive Disorder: Protocol for a Pilot Randomized Controlled TrialMojtaba Yekrang Safakar, Marianne Hrabok, Liana Urichuk, et al.
Plos One|February 9, 2010
Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variantsDavid Metzgar, Christopher A Myers, Kevin L Russell, et al.
ACS Chemical Neuroscience|March 4, 2022
Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand ComplexesAndrew D Cansfield, Mark A Ator, Joydeep Banerjee, et al.
Molecular Autism|October 26, 2019
Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autismHyung-Goo Kim, Jill A Rosenfeld, Daryl A Scott, et al.
Pageof 12